LINK WILLIAM J PHD
Director
- Shares
- 66
- Price
- $80.01
- Value
- $5,281
TARS
4 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$5,192,759
0 buyers · 4 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$12,676,834
6 distinct insiders
Highlighted alerts
3
36 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
TARS overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. RSUs granted on April 24, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on June 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service.
Reason: tax_withholding. The filing footnotes identify tax withholding.
Voluntary purchases and sales; administrative noise stays hidden.
LINK WILLIAM J PHD
Director
LINK WILLIAM J PHD
Director
LINK WILLIAM J PHD
Director
Lin Elizabeth Yeu
Chief Medical Officer
Lin Elizabeth Yeu
Chief Medical Officer
Lin Elizabeth Yeu
Chief Medical Officer
Lin Elizabeth Yeu
Chief Medical Officer
Azamian Bobak R.
President/CEO and Board Chair
Azamian Bobak R.
President/CEO and Board Chair
Neervannan Seshadri
Chief Operating Officer
Lin Elizabeth Yeu
Chief Medical Officer
Lin Elizabeth Yeu
Chief Medical Officer
Azamian Bobak R.
President/CEO and Board Chair
Lin Elizabeth Yeu
Chief Medical Officer
Azamian Bobak R.
President/CEO and Board Chair
Azamian Bobak R.
President/CEO and Board Chair
Goodrich Katherine
Director
LINK WILLIAM J PHD
Director
LINK WILLIAM J PHD
Director
Neervannan Seshadri
Chief Operating Officer
LINK WILLIAM J PHD
Director
LINK WILLIAM J PHD
Director
LINK WILLIAM J PHD
Director
Neervannan Seshadri
Chief Operating Officer
Whitfield Dianne C.
Chief Human Resources Officer
Whitfield Dianne C.
Chief Human Resources Officer
Whitfield Dianne C.
Chief Human Resources Officer
Whitfield Dianne C.
Chief Human Resources Officer
Azamian Bobak R.
President/CEO and Board Chair
Azamian Bobak R.
President/CEO and Board Chair
Whitfield Dianne C.
Chief Human Resources Officer
LINK WILLIAM J PHD
Director
LINK WILLIAM J PHD
Director
LINK WILLIAM J PHD
Director
LINK WILLIAM J PHD
Director
LINK WILLIAM J PHD
Director
Azamian Bobak R.
President/CEO and Board Chair
LINK WILLIAM J PHD
Director
Azamian Bobak R.
President/CEO and Board Chair
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | LINK WILLIAM J PHD Director | Sale | 66 | $80.01 | $5,281 | |
| Sep 15, 2026 | LINK WILLIAM J PHD Director | Sale | 759 | $79.00 | $59,961 | |
| Sep 15, 2026 | LINK WILLIAM J PHD Director | Sale | 11,675 | $78.33 | $914,503 | |
| Sep 04, 2026 | Lin Elizabeth Yeu Chief Medical Officer | Sale | 1,590 | $90.00 | $143,100 | |
| Sep 04, 2026 | Lin Elizabeth Yeu Chief Medical Officer | Sale | 1,590 | $85.00 | $135,150 | |
| Sep 04, 2026 | Lin Elizabeth Yeu Chief Medical Officer | Sale | 5,386 | $90.00 | $484,740 | |
| Sep 04, 2026 | Lin Elizabeth Yeu Chief Medical Officer | Sale | 5,387 | $85.00 | $457,895 | |
| Sep 04, 2026 | Azamian Bobak R. President/CEO and Board Chair | Sale | 2,900 | $91.27 | $264,683 | |
| Sep 04, 2026 | Azamian Bobak R. President/CEO and Board Chair | Sale | 7,100 | $90.27 | $640,917 | |
| Sep 04, 2026 | Neervannan Seshadri Chief Operating Officer | Sale | 4,564 | $85.00 | $387,940 | |
| Sep 02, 2026 | Lin Elizabeth Yeu Chief Medical Officer | Sale | 1,590 | $80.00 | $127,200 | |
| Sep 02, 2026 | Lin Elizabeth Yeu Chief Medical Officer | Sale | 5,387 | $80.00 | $430,960 | |
| Sep 02, 2026 | Azamian Bobak R. President/CEO and Board Chair | Sale | 10,000 | $80.06 | $800,600 | |
| Sep 01, 2026 | Lin Elizabeth Yeu Chief Medical Officer | Sale | 4,601 | $73.86 | $339,830 | |
| Jun 17, 2026 | Azamian Bobak R. President/CEO and Board Chair | Sale | 5,418 | $61.81 | $334,887 | |
| Jun 17, 2026 | Azamian Bobak R. President/CEO and Board Chair | Sale | 4,582 | $61.24 | $280,602 | |
| Jun 15, 2026 | Goodrich Katherine Director | Sale | 2,954 | $62.08 | $183,384 | |
| Jun 15, 2026 | LINK WILLIAM J PHD Director | Sale | 1,928 | $62.94 | $121,348 | |
| Jun 15, 2026 | LINK WILLIAM J PHD Director | Sale | 10,572 | $61.97 | $655,147 | |
| Mar 20, 2026 | Neervannan Seshadri Chief Operating Officer | Sale | 2,989 | $66.75 | $199,516 | |
| Mar 16, 2026 | LINK WILLIAM J PHD Director | Sale | 493 | $69.75 | $34,387 | |
| Mar 16, 2026 | LINK WILLIAM J PHD Director | Sale | 8,378 | $69.03 | $578,333 | |
| Mar 16, 2026 | LINK WILLIAM J PHD Director | Sale | 3,629 | $68.09 | $247,099 | |
| Mar 04, 2026 | Neervannan Seshadri Chief Operating Officer | Sale | 8,366 | $76.67 | $641,421 | |
| Jan 02, 2026 | Whitfield Dianne C. Chief Human Resources Officer | Sale | 893 | $82.93 | $74,056 | |
| Jan 02, 2026 | Whitfield Dianne C. Chief Human Resources Officer | Sale | 835 | $81.90 | $68,387 | |
| Jan 02, 2026 | Whitfield Dianne C. Chief Human Resources Officer | Sale | 8,122 | $80.71 | $655,527 | |
| Jan 02, 2026 | Whitfield Dianne C. Chief Human Resources Officer | Sale | 5,715 | $80.09 | $457,714 | |
| Dec 24, 2025 | Azamian Bobak R. President/CEO and Board Chair | Sale | 557 | $83.54 | $46,532 | |
| Dec 24, 2025 | Azamian Bobak R. President/CEO and Board Chair | Sale | 5,443 | $82.41 | $448,558 | |
| Dec 16, 2025 | Whitfield Dianne C. Chief Human Resources Officer | Sale | 7,397 | $80.10 | $592,500 | |
| Dec 15, 2025 | LINK WILLIAM J PHD Director | Sale | 4,766 | $81.50 | $388,429 | |
| Dec 15, 2025 | LINK WILLIAM J PHD Director | Sale | 5,680 | $80.71 | $458,433 | |
| Dec 15, 2025 | LINK WILLIAM J PHD Director | Sale | 1,148 | $82.39 | $94,584 | |
| Dec 15, 2025 | LINK WILLIAM J PHD Director | Sale | 6,306 | $81.75 | $515,516 | |
| Dec 15, 2025 | LINK WILLIAM J PHD Director | Sale | 5,046 | $80.80 | $407,717 | |
| Sep 24, 2025 | Azamian Bobak R. President/CEO and Board Chair | Sale | 6,000 | $55.37 | $332,220 | |
| Sep 08, 2025 | LINK WILLIAM J PHD Director | Sale | 27,116 | $57.00 | $1,545,612 | |
| Aug 11, 2025 | Azamian Bobak R. President/CEO and Board Chair | Sale | 6,000 | $50.00 | $300,000 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.